Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT03664739. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel
Study identification
- NCT ID
- NCT03664739
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 608 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 4, 2018
- Primary completion
- Mar 22, 2020
- Completion
- Mar 22, 2020
- Last update posted
- Mar 28, 2023
2018 – 2020
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 123 | Mobile | Alabama | 36608 | — |
| Valeant Site 121 | Hot Springs | Arkansas | 71913 | — |
| Valeant Site 120 | Beverly Hills | California | 90212 | — |
| Valeant Site 117 | Encinitas | California | 92024 | — |
| Valeant Site 107 | Fremont | California | 94538 | — |
| Valeant Site 104 | San Diego | California | 92123 | — |
| Valeant Site 128 | Denver | Colorado | 80220 | — |
| Valeant Site 115 | Wheat Ridge | Colorado | 80033 | — |
| Valeant Site 113 | Clearwater | Florida | 33761 | — |
| Valeant Site 122 | North Miami Beach | Florida | 33162 | — |
| Valeant Site 103 | West Palm Beach | Florida | 33401 | — |
| Valeant Site 101 | Oakbrook Terrace | Illinois | 60181 | — |
| Valeant Site 124 | Evansville | Indiana | 47715 | — |
| Valeant Site 111 | Louisville | Kentucky | 40217 | — |
| Valeant Site 118 | Largo | Maryland | 20774 | — |
| Valeant Site 129 | Needham | Massachusetts | 20492 | — |
| Valeant Site 119 | Detroit | Michigan | 48202 | — |
| Valeant Site 126 | New York | New York | 10076 | — |
| Valeant Site 108 | High Point | North Carolina | 27262 | — |
| Valeant Site 106 | Oklahoma City | Oklahoma | 73112 | — |
| Valeant Site 109 | Austin | Texas | 78759 | — |
| Valeant Site 130 | Pflugerville | Texas | 78660 | — |
| Valeant Site 105 | San Antonio | Texas | 78218 | — |
| Valeant Site 110 | Norfolk | Virginia | 23507 | — |
| Valeant Site 116 | Walla Walla | Washington | 99362 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03664739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 28, 2023 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03664739 live on ClinicalTrials.gov.